UCLA researchers show a cancer defense mechanism could be turned back to attack tumors – UCLA Newsroom
UCLA Newsroom |
UCLA researchers show a cancer defense mechanism could be turned back to attack tumors
UCLA Newsroom “We have generated the first example of a CAR that can help white blood cells — specifically T cells — convert tumor-produced proteins from suppressants, or ‘downers’ for our immune system, into stimulants that trigger robust attacks on the tumor … |
Phys.Org |
Drug-producing bacteria possible with synthetic biology breakthrough
Science Daily Led by the Warwick Integrative Synthetic Biology Centre at Warwick’s School of Engineering and the Faculty of Health and Medical Sciences at the University of Surrey, new research has discovered how to dynamically manage the allocation of essential … Drug-producing bacteria possible with synthetic biology breakthroughPhys.Org Synthetic Biology Market: By Tool; By Technology; By Application & By Geography – Forecast (2017-2023 …satPRnews (press release) |
|
Sorrento’s liver artery-infused CAR–T cells showed positive effect in early-stage study
Seeking Alpha Results from three heavily pretreated patients with CEA-positive liver metastases in a Phase 1b clinical trial who received Sorrento Therapeutics’ (SRNE -1.4%) autologous anti-CEA CAR–T cells via hepatic artery infusion showed a treatment effect … Sorrento (SRNE) Says Anti-CEA CAR-T Cell Therapy for Liver …StreetInsider.com Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for …GlobeNewswire (press release) |